Cargando…

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections

Detalles Bibliográficos
Autores principales:	Martinez-Sobrido, Luis, Kobie, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944790/ https://www.ncbi.nlm.nih.gov/pubmed/36810517 http://dx.doi.org/10.3390/antib12010012

Ejemplares similares

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Assessing Immune Response to SARS-CoV-2 Infection
por: Shurin, Michael R, et al.
Publicado: (2020)

Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
por: Chiem, Kevin, et al.
Publicado: (2022)

The Antibody Response to SARS-CoV-2 Infection
por: Hueston, Linda, et al.
Publicado: (2020)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection
por: Vieira, Sandra Elisabete, et al.
Publicado: (2020)

Antibody and B cell responses to SARS-CoV-2 infection and vaccination
por: Röltgen, Katharina, et al.
Publicado: (2021)

Special Issue “SARS-CoV-2 Innate and Adaptive Immune Responses”
por: Planes, Rémi, et al.
Publicado: (2022)

Antibody Response to SARS CoV-2 Immunization in Patients with Immunodeficiency
por: DiGiacomo, Daniel, et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS-CoV-2 infection and immune responses
por: Harne, Rakhi, et al.
Publicado: (2023)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

COVID-19 Gastrointestinal Symptoms and Attenuation of the Immune Response to SARS-CoV-2
por: Miller, Jonathan, et al.
Publicado: (2021)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
por: Piepenbrink, Michael S., et al.
Publicado: (2021)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
por: Ye, Chengjin, et al.
Publicado: (2023)

Advanced Materials for SARS‐CoV‐2 Vaccines
por: Mabrouk, Moustafa T., et al.
Publicado: (2022)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

Dynamics and significance of the antibody response to SARS-CoV-2 infection
por: Iyer, Anita S., et al.
Publicado: (2020)

A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

How SOLID is the immune system’s response to the deadly duo of lung cancer and SARS-CoV-2?
por: Narvel, Hiba, et al.
Publicado: (2022)

Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
por: Files, Jacob K., et al.
Publicado: (2021)

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

Probing the early upper respiratory responses to SARS‐CoV‐2
por: Jamieson, Amanda M.
Publicado: (2021)

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection
por: Delgado, Juan F., et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

Immune responses to SARS-CoV-2 infection and vaccination in children
por: Brodin, Petter
Publicado: (2023)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals
por: Robbiani, Davide F., et al.
Publicado: (2020)

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
por: Anichini, Gabriele, et al.
Publicado: (2021)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
por: Anand, Shuchi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j0ukuvts74hlu3b72rghv15ujn